Recombinant human Erythropoietin enhanced the cytotoxic effects of tamoxifen toward the spheroid MCF-7 breast cancer cells

Recombinant human Erythropoietin enhanced the cytotoxic effects of tamoxifen toward the spheroid MCF-7 breast cancer cells

Erythropoietin (EPO) is widely used to treat anemia in patients undergoing chemotherapy for cancers. The main objective of this study was to investigate the effect of rHuEPO on the response of spheroid breast cancer, MCF-7, cells to tamoxifen treatment. The MCF-7 spheroids were treated with 10 mg/mL...

Full description

Bibliographic Details
Main Authors: Hareth Y. Shujaa Edin, Nagi A. AL-Haj, Abdullah Rasedee, Noorjahan Banu Alitheen, Arifah Abdul Kadir, Chee Wun How, Heshu Sulaiman Rahman, Hussah Abdullah AL-Shwyeh
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:Saudi Journal of Biological Sciences
Subjects:
Recombinant human erythropoietin
Tamoxifen
Spheroids
Hanging drop
Ultra-low adhesive plate
Overlay technique
Online Access:http://www.sciencedirect.com/science/article/pii/S1319562X21004113

Internet

http://www.sciencedirect.com/science/article/pii/S1319562X21004113

Similar Items